Literature DB >> 6853263

The influence of surgery and radiation therapy on patients with brain metastases.

F R Hendrickson, M S Lee, M Larson, R D Gelber.   

Abstract

The place for operation and for radiation therapy in the management of brain metastases is reviewed from the experience of 1895 patients treated in two studies of the Radiation Therapy Oncology Group. Operative removal may be of benefit to patients with solitary peripheral lesions in non-critical brain locations. Operation is also appropriate when the diagnosis is in doubt. Radiation therapy with appropriate steroid management is of benefit to patients with multiple metastases or where operative intervention is not reasonable. Short course low-dose treatment has been as beneficial as more aggressive prolonged radiation therapy.

Entities:  

Mesh:

Year:  1983        PMID: 6853263     DOI: 10.1016/0360-3016(83)90226-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  The prognostic factors of lung cancer patients with brain metastases treated with radiotherapy.

Authors:  C Y Hsiung; S W Leung; C J Wang; S K Lo; H C Chen; L M Sun; F M Fang
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

2.  Treatment and outcome of brain metastasis as first site of distant metastasis from breast cancer.

Authors:  W Boogerd; A A Hart; I S Tjahja
Journal:  J Neurooncol       Date:  1997-11       Impact factor: 4.130

3.  Radiation therapy for brain metastases.

Authors:  G E Sheline; L W Brady
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

4.  Commentary on diagnosis and surgical management of metastatic brain tumors.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 5.  Optimal management of brain metastases from breast cancer. Issues and considerations.

Authors:  Rupert Bartsch; Anna S Berghoff; Matthias Preusser
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

6.  Palliative radio-chemotherapy with ifosfamide and BCNU for breast cancer patients with cerebral metastases. A 5-year experience.

Authors:  O F Lange; W Scheef; K D Haase
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer.

Authors:  Rupert Bartsch; Andrea Rottenfusser; Catharina Wenzel; Karin Dieckmann; Ursula Pluschnig; Gabriela Altorjai; Margaretha Rudas; Robert M Mader; Richard Poetter; Christoph C Zielinski; Guenther G Steger
Journal:  J Neurooncol       Date:  2007-06-08       Impact factor: 4.130

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.